Literature DB >> 9176701

Factors controlling the turnover of T memory cells.

J Sprent1, D F Tough, S Sun.   

Abstract

Most of the T cells participating in the primary immune response are rapidly eliminated, but small numbers of these cells survive and differentiate into long-lived memory cells. Information on the life history of memory cells can be obtained by studying the component of memory-phenotype T cells found in normal animals; these cells are presumed to represent memory cells specific for various environmental antigens. For CD8+ cells, in vivo exposure to viruses and certain other infectious agents causes a large proportion of memory-phenotype (CD44hi) cells to enter the cell cycle. In this situation, stimulation of CD44hi CD8+ cells does not seem to require T-cell receptor ligation and appears to reflect release of various cytokines, especially type I interferon. The capacity of infectious agents to induce non-antigen-specific stimulation of T cells may play a role in boosting the survival of memory cells and perhaps also in providing an adjuvant function during the primary response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176701     DOI: 10.1111/j.1600-065x.1997.tb00960.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  10 in total

1.  In vivo proliferation of naïve and memory influenza-specific CD8(+) T cells.

Authors:  K J Flynn; J M Riberdy; J P Christensen; J D Altman; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

Review 2.  Differences in the regulation of CD4 and CD8 T-cell clones during immune responses.

Authors:  P C Beverley; M K Maini
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

Review 3.  The organization of mature T-cell pools.

Authors:  C Tanchot; H V Fernandes; B Rocha
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

4.  Activated T lymphocytes disappear from circulation during endotoxemia in humans.

Authors:  K S Krabbe; H Bruunsgaard; J Qvist; L Fonsmark; K Møller; C M Hansen; P Skinhøj; B K Pedersen
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

5.  Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia.

Authors:  W Nicholas Haining; Donna S Neuberg; Heather L Keczkemethy; John W Evans; Stephen Rivoli; Rebecca Gelman; Howard M Rosenblatt; William T Shearer; Javier Guenaga; Daniel C Douek; Lewis B Silverman; Stephen E Sallan; Eva C Guinan; Lee M Nadler
Journal:  Blood       Date:  2005-05-26       Impact factor: 22.113

6.  Naïve and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implicatip6s for transmission and pathogenesis.

Authors:  J L Riley; B L Levine; N Craighead; T Francomano; D Kim; R G Carroll; C H June
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  Old mice express a transient early resistance to pulmonary tuberculosis that is mediated by CD8 T cells.

Authors:  Joanne Turner; Anthony A Frank; Ian M Orme
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

8.  Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses.

Authors:  S Mori; H Nakano; K Aritomi; C R Wang; M D Gunn; T Kakiuchi
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

9.  Tumor necrosis factor-alpha induces VCAM-1-mediated inflammation via c-Src-dependent transactivation of EGF receptors in human cardiac fibroblasts.

Authors:  Chih-Chung Lin; Chih-Shuo Pan; Chen-Yu Wang; Shiau-Wen Liu; Li-Der Hsiao; Chuen-Mao Yang
Journal:  J Biomed Sci       Date:  2015-07-15       Impact factor: 8.410

10.  Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells.

Authors:  Laura Rivino; Mara Messi; David Jarrossay; Antonio Lanzavecchia; Federica Sallusto; Jens Geginat
Journal:  J Exp Med       Date:  2004-09-20       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.